Skip to main content
. 2019 May 16;20(10):2420. doi: 10.3390/ijms20102420

Figure 2.

Figure 2

Action mechanisms of genistein to exert anticancer effects. Genistein exhibits anticancer effects by inhibiting the activities of receptor tyrosine kinase including EGFR and serine/threonine cell cycle regulatory kinases such as PLK1 and CDK1. Genistein also suppresses the transcriptional expression of PLK1. It is also considered as a tissue-specific hormone modulator.